Adriana T. Nishiya
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Prognostic significance of lymphatic vessel density in canine cutaneous mast cell tumors.
Journal: Veterinary pathology
Published: December 26, 2025
Targeting canine mammary neoplastic epithelial cells with a reengineered anthrax toxin: first study.
Targeting canine mammary neoplastic epithelial cells with a reengineered anthrax toxin: first study.
Journal: Veterinary research communications
Published: January 08, 2024
Diagnosis, Prognosis, and Treatment of Canine Hemangiosarcoma: A Review Based on a Consensus Organized by the Brazilian Association of Veterinary Oncology, ABROVET.
Journal: Cancers
Published: February 16, 2023
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours.
Journal: Veterinary and comparative oncology
Published: September 23, 2022
Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors.
Journal: Cells
Published: December 10, 2021
Galectin-3 immunolabelling correlates with BCL2 expression in canine cutaneous mast cell tumours.
Journal: Acta veterinaria Hungarica
Published: December 27, 2020
Inhibitory Effects of a Reengineered Anthrax Toxin on Canine and Human Osteosarcoma Cells.
Journal: Toxins
Published: June 25, 2020
Inhibitory Effects of a Reengineered Anthrax Toxin on Canine Oral Mucosal Melanomas.
Journal: Toxins
Published: January 16, 2020
Intratumoral collagen index predicts mortality and survival in canine cutaneous mast cell tumours.
Journal: Veterinary dermatology
Published: December 03, 2018
Last Updated: 09/26/2026